Penumbra, Inc. (PEN) — Stock Score Summary

Penumbra, Inc. (PEN) has a MoatMap StockRank of 75/100 based on Quality (78/100), Value (16/100), and Momentum (64/100) factor scores. The current signal is BUY. Penumbra is a high-quality medical device company with strong market share in thrombectomy. However, at current valuations, it lacks a clear connection to our active macro themes, and the risk-reward is not sufficiently asymmetric.

Penumbra, Inc. designs, develops, manufactures, and markets innovative medical devices for neurovascular and peripheral vascular diseases. The company is a niche market leader in advanced interventional therapies, particularly for stroke and vascular embolization, driven by a strong R&D pipeline. Penumbra focuses on highly specialized, minimally invasive technologies that significantly improve patient outcomes.

Key Financial Metrics

Price$319.37
Market Cap$12.5B
P/E (TTM)74.05
P/E (Forward)50.96
Price/Book8.81
Return on Equity12.7%
Return on Invested Capital12.6%
Debt/Equity14.67
Gross Margin67.4%
Operating Margin10.2%
Revenue Growth15.6%
Free Cash Flow$142M

Penumbra, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Penumbra, Inc.’s (PEN) StockRank?
MoatMap’s StockRank for Penumbra, Inc. (PEN) is 75/100, with a Buy signal. It is a composite of Quality (78), Value (16), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Penumbra, Inc. have an economic moat?
Penumbra, Inc. (PEN) has a Quality factor score of 78/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Penumbra, Inc. a buy, hold, or sell?
MoatMap’s current signal for Penumbra, Inc. (PEN) is Buy, based on a StockRank of 75/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Penumbra, Inc. in?
Penumbra, Inc. (PEN) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksPEN deep dive reportAI ChampionsHow we score stocksSense-check another stock